Lv1
90 积分 2024-09-04 加入
Safety and Complications Associated With the Use of Protamine in Percutaneous Coronary Intervention
1个月前
已关闭
Safety and Complications Associated With the Use of Protamine in Percutaneous Coronary Intervention
1个月前
已关闭
Total Event Analysis in Cardiovascular Outcome Trials: Approaches and Interpretation
3个月前
已完结
Bivalirudin versus Heparin on Net Adverse Clinical Events, Major Adverse Cardiac and Cerebral Events, and Bleeding in Elderly Chinese Patients Treated with Percutaneous Coronary Intervention
3个月前
已关闭
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction
3个月前
已完结
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction
3个月前
已完结
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
3个月前
已完结
Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
3个月前
已完结
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
3个月前
已完结
皖公网安备34019202002308
